GalaExtra is an in-house research report featuring undervalued public companies primarily listed on the NASDAQ, NYSE, and TSX. We expect to expand this service to include opportunities with quality crypto speculations.
Our reports detail exciting undervalued companies in sectors with substantial growth potential such as Biotech, Fin-tech, Defense and many other sectors with unrealized profitability.
Our reports are easy to follow and make for engaging material for the sophisticated speculator.
Please consult with a licensed and qualified financial advisor before making investment decisions.
Sign up to receive priority delivery of these valuable reports right to your inbox.
Top FTSE 100 UK Dividend Paying Stocks – ISA Season…
As part of our ISA special report week, we’re looking at income investing within the framework of tax-free saving – as well as the...
Top FTSE 100 Dividend Paying Stocks
Earnings season is fast approaching here and we expect a raft of dividend updates from FTSE 100 companies in the coming weeks. Until then,...
UK Equities Kick Off 2024 Under Shadow of Inflation
The increased has once more placed the UK's equity market under overcast skies, after initial hopes a new year and a revamped listing regime...
Bonds Are Attractive: Morningstar’s Outlook for 2024
“Say Yes to Bonds” is the one of the key calls of Morningstar Investment Management (MIM) 2024 outlook, along with “Risk Creates Opportunity” and...
The United States vs. Canada: Differences in Investing
Investing has some universality to it. From Afghanistan to Zimbabwe, deferring today's consumption to build tomorrow's fortune is largely the same. Let's compare two...
